Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 12, 2013
Grant Date -
Sep 1, 2011
app pub date -
May 11, 2011
filing date -
Oct 30, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein is a combination therapy and a combination preparation of an angiotensin-II-receptor blocker and an HMG-CoA reductase inhibitor characterized in that the angiotensin-II-receptor blocker is absorbed substantially later than the HMG-CoA reductase inhibitor. As the angiotensin-II-receptor blocker and the HMG-CoA reductase inhibitor are released at different times, the present combination therapy prevents competitive inhibition between the two drugs and side effects, as well as simultaneously provides synergistic effects for each active ingredient and convenience of taking the drugs.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully